Sukesh Voruganti

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer

Elizabeth A. McMillan, Myung‐Jeom Ryu, Caroline H. Diep et al. · Cell · 2018 · 147 citations · Full text

Medicine, Chemistry, Oncology +14

The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models

Wei Wang, Jiang‐Jiang Qin, Sukesh Voruganti et al. · Nature Communications · 2014 · 99 citations · Full text

Medicine, Medicinal Chemistry, Oncology +8

Identification of a New Class of MDM2 Inhibitor That Inhibits Growth of Orthotopic Pancreatic Tumors in Mice

Wei Wang, Jiang‐Jiang Qin, Sukesh Voruganti et al. · Gastroenterology · 2014 · 81 citations · Full text

Medicine, Oncology, Pharmacology +9

Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2

Wei Wang, Xu Zhang, Jiang‐Jiang Qin et al. · PLoS ONE · 2012 · 81 citations · Full text

Medicine, Oncology, Pharmacology +13

Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization,<i>in vitro</i>and<i>in vivo</i>anti-prostate cancer activity, and mechanisms of action

Sukesh Voruganti, Jiang‐Jiang Qin, Sushanta Sarkar et al. · Oncotarget · 2015 · 63 citations · Full text

Pharmacy, Oncology, Pharmacology +17